Helping to Treat Neuropathic Pain and Anemia with an Iranian Supplement
January 29, 2025
In a ceremony attended by specialists in endocrinology, neurology, and nutrition, Nexus, a subsidiary of the Actoverco Pharmaceutical Group, unveiled its new product, “Neurostyle.”
Dr. Roxana Kia, CEO of Nexus Pharmaceutical Company, announced that this supplement, produced in tablet form by Nexus specialists from the Actoverco Pharmaceutical Group, can be used by both ordinary individuals and those with diabetes who have difficulties with medication injections.
She stated that the ingredients used in the Neurostyle supplement include B vitamins, and emphasized that in addition to diabetic patients, individuals over 65, patients who have undergone gastrointestinal surgeries, and vegetarians are other groups that can benefit from the positive effects of this product.
She also mentioned that Nexus has distributed new products in the form of tablets, soft gels, and effervescent tablets, and plans to produce and market sachets and oral vials in the near future. She announced plans for a serious entry into the export market for these supplements.
Attend
Events
Related
Content
Diabetes and Physical Activity
Tina Rezaei,
January 6, 2025
Presentation of Actover’s latest products at the Gastrointestinal and Liver Diseases Congress
Tina Rezaei,
January 6, 2025
Introduction of Actoverco Cardiovascular Medications at the 8th International Heart Failure Congress
Tina Rezaei,
January 6, 2025
Diabetes and Physical Activity
Tina Rezaei,
November 4, 2024
اولین نفری باشید که از جدیدترین رویدادهای آینده مطلع می شوید!
Be the first to get notified of the newest upcomings !